BurgerFi to Report Third Quarter 2022 Financial Results on November 16, 2022

Written by Customer Service on November 11, 2022. Posted in Public Companies.

FORT LAUDERDALE, Fla., Nov. 11, 2022 (GLOBE NEWSWIRE) — BurgerFi International, Inc. (NASDAQ: BFI, BFIIW) (“BurgerFi”), owner of one of the nation’s leading fast-casual “better burger” dining concepts through the BurgerFi brand, and the high-quality, casual dining pizza brand under the name Anthony’s Coal Fired Pizza & Wings (“Anthony’s”), will report financial results for the third quarter ended October 3, 2022 on Wednesday, November 16, 2022 before the market opens. Management will host a conference call at 8:30 a.m. Eastern time on the same day to discuss the results. The conference call will be broadcast live and available for replay on the Company’s Investor Relations website at ir.burgerfi.com. Participants can also access the call using the dial-in details below. Date: Wednesday, November 16, 2022Time: 8:30 a.m. ETToll-free...

Innofactor Plc: Share Repurchase 11.11.2022

Written by Customer Service on November 11, 2022. Posted in Public Companies.

Innofactor Plc Announcement 11.11.2022 Innofactor Plc: Share Repurchase 11.11.2022 In the Helsinki Stock Exchange Trade date 11.11.2022 Bourse trade Buy Share IFA1V Amount 3,842 Shares Average price/ share 0.9760 EUR Total cost 3,749.79 EUR Innofactor Plc now holds a total of 1 015 042 shares including the shares repurchased on 11.11.2022 On behalf of Innofactor Plc Nordea Bank Oyj Janne Sarvikivi Sami Huttunen Additional information: Sami Ensio, CEO Innofactor Plc Tel. +358 50 584 2029 sami.ensio@innofactor.com www.innofactor.com Attachment Innofactor_11.11_trades

Bavarian Nordic to Present at Jefferies 2022 London Healthcare Conference

Written by Customer Service on November 11, 2022. Posted in Public Companies.

COPENHAGEN, Denmark – November 11, 2022 – Bavarian Nordic A/S (OMX: BAVA) today announced that Paul Chaplin, President & CEO will provide a corporate presentation at the Jefferies 2022 London Healthcare Conference on Thursday, November 17, 2022 at 8:35 am GMT (9:35 am CET). A live and archived webcast of the presentation will be available at https://www.bavarian-nordic.com/investor/events.aspx?event=6652. ContactsEurope: Rolf Sass Sørensen, Vice President Investor Relations & Communications. Phone +45 61 77 47 43 U.S.: Graham Morrell, Paddock Circle Advisors (US), Tel: +1 781 686 9600 About Bavarian NordicBavarian Nordic is a fully integrated vaccines company focused on the development, manufacturing and commercialization of life-saving vaccines. We are a global leader in smallpox vaccines and have been a long-term supplier...

Ålandsbanken Abp: Acquisitions of own shares 11.11.2022

Written by Customer Service on November 11, 2022. Posted in Public Companies.

Ålandsbanken Abp Changes in company’s own shares11.11.2022 at 18:30 EET Ålandsbanken Abp: Acquisitions of own shares 11.11.2022 Date 11.11.2022 ExchangeBourse trade Nasdaq Helsinki Oy (XHEL)Buy Share class ALBBV Amount 285 Average price/share 32.9000 EUR Highest price/share 32.9000 EUR Lowest price/share 32.9000 EUR Total price 9,376.50 EUR The shares held by Ålandsbanken Abp on 11.11.2022: ALBBV 12,988 On behalf of Ålandsbanken Abp Skandinaviska Enskilda Banken AB (Publ) Antti Salakka Janne Tiihonen For more information, please contact: Peter Wiklöf, Managing Director and Chief Executive,...

Candel Therapeutics Announces Late-Breaking Oral Presentation at SITC Annual Meeting with Data on CAN-2409 in Combination with Nivolumab in a Phase 1 Mechanistic Clinical Trial in Patients with High-Grade Glioma

Written by Customer Service on November 11, 2022. Posted in Public Companies.

Combination of nivolumab and CAN-2409 delivered during neurosurgery was generally well tolerated with no significant added toxicity compared to standard of care Systemic immune activation was observed in peripheral blood following administration of CAN-2409/valacyclovir prior to nivolumab treatment Median overall survival (mOS) for patients with methylated MGMT promoter was 30.6 months for those undergoing gross total resection (GTR) and 12.6 months for those undergoing sub-total resection (STR). For patients with unmethylated MGMT promotor, mOS was 13.2 months and 15.9 months, respectively. NEEDHAM, Mass., Nov. 11, 2022 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical stage biopharmaceutical company developing novel viral immunotherapies, today announced presentation of late-breaking data from a phase...

Rovio Entertainment Corporation: Repurchase of own shares on 11 November 2022

Written by Customer Service on November 11, 2022. Posted in Public Companies.

Rovio Entertainment Oyj STOCK EXCHANGE RELEASE 11.11.2022 at 18.45 EET Rovio Entertainment Corporation – Repurchase of own shares on 11.11.2022 Rovio Entertainment Corporation In the Nasdaq Helsinki Date 11.11.2022 Exchange transaction BUY Share trading code ROVIO Amount, shares 42464 Average price/share, EUR 6,188434 Total cost, EUR 262785,65 Rovio now holds a total of 5 982 558 shares including the shares repurchased on 11.11.2022 On behalf of Rovio Entertainment Corporation OP Corporate Bank PLC Further information:Timo Rahkonen, VP Investor Relations & Corporate Strategy +358 40 730 3442 RovioIR@rovio.com Distribution:Nasdaq Helsinki LtdKey mediawww.rovio.com About Rovio:Rovio Entertainment Corporation is a global mobile-first games company that creates,...

Global Bioenergies renews equity line with Kepler Cheuvreux to support industrial deployment

Written by Customer Service on November 11, 2022. Posted in Public Companies.

Global Bioenergies renews equity line with Kepler Cheuvreux to support industrial deployment Evry, 11 November 2022 Global Bioenergies today announces the renewal of its equity line with Kepler Cheuvreux, a leading European financial services company acting as ISP1 as part of an underwriting agreement. This financing solution with Kepler Cheuvreux has already been a well-proven success for Global Bioenergies: the two-year contract signed in August 2020 raised €13.6 million and the valuation of Global Bioenergies doubled over the same period. This transaction aims to strengthen the Company’s financial structure. The funds raised will mainly go towards prefinancing the production of Isonaturane® 12 on the new “Horizon 2” line and performing engineering studies for the 2,000 tonne/year Horizon 3 plant, construction of which is to be financed...

Invitation to presentation of Copperstone Resources interim report for the third quarter 2022

Written by Customer Service on November 11, 2022. Posted in Public Companies.

Kiruna November 11, 2022 Copperstone Resources’ interim report for January – September 2022 will be published on Friday, November 18th, 2022 at 07:30 CET. A live presentation will be held the same day at 9:00 am hosted by Infront Direkt Studio. The report is presented by CEO Anna Tyni and Jörgen Olsson, executive Chairman of the Board. The presentation will be held in Swedish and includes a Q&A session. Date: Friday, November 18th Time: The report is published at 07:30 and the live presentation starts at 9:00 CET. The live presentation can be accessed via the link below: https://youtu.be/EzNWu0r9NVw The interim report, the presentation and a recorded version of the presentation will also be available on the company’s website: https://copperstone.se/en/for-investors/reports/ For further information, please contact Anna...

Stericycle to Participate in Oppenheimer Midwest Industrial Virtual Summit in December

Written by Customer Service on November 11, 2022. Posted in Public Companies.

BANNOCKBURN, Ill., Nov. 11, 2022 (GLOBE NEWSWIRE) — Stericycle, Inc. (Nasdaq: SRCL) today announced that Cindy J. Miller, Chief Executive Officer, and Janet Zelenka, Chief Financial Officer and Chief Information Officer, will participate in investor meetings at the Oppenheimer Midwest Industrial Virtual Summit on December 15, 2022. About StericycleStericycle, Inc., (Nasdaq: SRCL) is a U.S. based business-to-business services company and leading provider of compliance-based solutions that protect people and brands, promote health and well-being and safeguard the environment. Stericycle serves customers in the U.S. and 16 other countries worldwide with solutions for regulated waste and compliance services, secure information destruction and patient engagement. For more information about Stericycle, please visit stericycle.com. FOR...

Update regarding expected timing of merger between Nordax Bank AB (publ) and Bank Norwegian ASA

Written by Customer Service on November 11, 2022. Posted in Public Companies.

As previously announced, Nordax Bank AB (publ) (rated BBB/N3/Stable from Nordic Credit Rating) and Bank Norwegian ASA are in the process of implementing an intragroup merger between the companies. As announced on 1 November 2022, all necessary regulatory approvals to complete the merger have been obtained. As of today, all consents and approvals have been obtained from relevant third parties. The merger will be implemented with Nordax Bank AB (publ) as the surviving company and Bank Norwegian as the transferring company. The merger is expected to be completed on or about 30 November 2022. Contact persons: CEO, Klara-Lise Aasen; phone +47 47 63 55 83; kaa@banknorwegian.no CFO, Mats Benserud; phone +47 95 89 15 39; mbe@banknorwegian.no This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities...

Day: November 11, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice